Low efficacy of an ultra-short term, once-daily dose triple therapy with omeprazole, azithromycin, and secnidazole for Helicobacter pylori eradication in peptic ulcer
Rev. Hosp. Clin. Fac. Med. Univ. Säo Paulo
;
57(1): 9-14, Jan.-Feb. 2002. tab
Article
Dans Anglais
| LILACS
| ID: lil-311299
RESUMO
PURPOSE:
To determine the eradication rate of an ultra-short treatment schedule for Helicobacter pylori infection in a population with peptic ulcers, using omeprazole, secnidazole, and azithromycin in a once-daily dose for 3 days.METHODS:
Thirty patients with peptic ulcer diagnosed by upper endoscopy and for Helicobacter pylori infection by rapid urease test and histologic examination received omeprazole 40 mg, secnidazole 1000 mg, and azithromycin 500 mg, administered once daily for 3 days. A follow-up exam was performed 12 weeks after the end of the treatment. Patients who were negative for Helicobacter pylori infection by rapid urease test and histologic examination were considered cured.RESULTS:
Patients were predominantly female, and the mean age was 50 years. Duodenal peptic ulcer was found in 73 percent of the patients. Eradication was achieved in 9 of the 28 (32 percent) patients as determined from the follow-up endoscopic exam. The eradication rate by intention to treat was 30 percent. Side effects were present in 3 percent of the patients, and compliance to treatment was total.CONCLUSIONS:
In spite of the low rate of side effects and good compliance, the eradication index was low. A possible drawback of this therapy is that it reduces the efficacy of macrolide and nitroimidazole compounds in subsequent treatments
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Ulcère peptique
/
Oméprazole
/
Helicobacter pylori
/
Azithromycine
/
Métronidazole
/
Antiulcéreux
/
Antibactériens
/
Antiprotozoaires
Limites du sujet:
Adulte
/
Femelle
/
Humains
/
Mâle
langue:
Anglais
Texte intégral:
Rev. Hosp. Clin. Fac. Med. Univ. Säo Paulo
Thème du journal:
Médicament
Année:
2002
Type:
Article
Pays d'affiliation:
Brésil
Institution/Pays d'affiliation:
University of Säo Paulo/BR
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS